Health Care & Life Sciences » Biotechnology | NanoString Technologies Inc.

NanoString Technologies Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
31,403.00
47,593.00
62,667.00
86,489.00
114,905.00
106,732
Cost of Goods Sold (COGS) incl. D&A
15,009.00
21,149.00
26,126.00
30,245.00
31,880.00
36,331
Gross Income
16,394.00
26,444.00
36,541.00
56,244.00
83,025.00
70,401
SG&A Expense
44,891.00
72,467.00
77,783.00
97,420.00
121,222.00
148,285
EBIT
28,497.00
46,023.00
41,242.00
41,176.00
38,197.00
77,884
Unusual Expense
1,156.00
600.00
-
-
-
842
Non Operating Income/Expense
66.00
147.00
389.00
515.00
183.00
1,658
Interest Expense
1,942.00
3,540.00
4,017.00
5,672.00
6,153.00
6,589
Pretax Income
29,281.00
50,038.00
45,415.00
46,973.00
43,358.00
85,642
Income Tax
-
-
166.00
116.00
204.00
8,242
Consolidated Net Income
33,934.00
50,038.00
45,581.00
47,089.00
43,562.00
77,400
Net Income
33,934.00
50,038.00
45,581.00
47,089.00
43,562.00
77,400
Net Income After Extraordinaries
33,934.00
50,038.00
45,581.00
47,089.00
43,562.00
77,400
Net Income Available to Common
33,934.00
50,038.00
45,581.00
47,089.00
43,562.00
77,400
EPS (Basic)
4.44
2.80
2.40
2.34
1.84
2.78
Basic Shares Outstanding
7,643.00
17,839.00
19,027.00
20,116.00
23,731.00
27,883
EPS (Diluted)
4.44
2.80
2.40
2.34
1.84
2.78
Diluted Shares Outstanding
7,643.00
17,839.00
19,027.00
20,116.00
23,731.00
27,883
EBITDA
26,720.00
44,484.00
38,865.00
38,199.00
34,843.00
73,814
Non-Operating Interest Income
68.00
272.00
233.00
390.00
809.00
1,331
Other After Tax Income (Expense)
4,653.00
-
-
-
-
-

About NanoString Technologies

View Profile
Address
530 Fairview Avenue North
Seattle Washington 98109
United States
Employees -
Website http://www.nanostring.com
Updated 07/08/2019
NanoString Technologies, Inc. engages in the provision of life science tools for translational research and molecular diagnostic products. It offers analysis solutions, gene expression panels, protein assays, DNA Assaya, miRNA assays, vantage 3D assays, custom solutions, sample prep and nCounter consumables, and nDesign gateway. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.